FGFC1 also exerted significantly inhibitory effect on erlotinib-resistant H1975 NSCLC cells proliferation, while only slightly inhibitory effect on EGFR wild type cells A549 and H1299 (Figures 1E–H). This evidence concerns the gene EGFR and non-small cell lung carcinoma.